342 related articles for article (PubMed ID: 17102649)
1. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
Stief TW
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
Stief TW
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
[TBL] [Abstract][Full Text] [Related]
3. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
Stief TW
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
[TBL] [Abstract][Full Text] [Related]
4. The intrinsic coagulation activity assay.
Stief TW; Otto S; Renz H
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
[TBL] [Abstract][Full Text] [Related]
5. Influence of coagulation factors on extrinsic thrombin generation.
Stief TW; Wieczerzak A; Renz H
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):105-12. PubMed ID: 17287625
[TBL] [Abstract][Full Text] [Related]
6. The extrinsic coagulation activity assay.
Stief TW; Wieczerzak A; Renz H
Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
[TBL] [Abstract][Full Text] [Related]
7. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
Mischke R; Grebe S
Res Vet Sci; 2000 Dec; 69(3):241-7. PubMed ID: 11124095
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition.
Momi S; Nasimi M; Colucci M; Nenci GG; Gresele P
Haematologica; 2001 Mar; 86(3):297-302. PubMed ID: 11255277
[TBL] [Abstract][Full Text] [Related]
9. Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
Stief TW
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):619-21. PubMed ID: 22821003
[TBL] [Abstract][Full Text] [Related]
10. Specific determination of plasmatic thrombin activity.
Stief TW
Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.
Stief TW
Clin Appl Thromb Hemost; 2006 Apr; 12(2):137-61. PubMed ID: 16708116
[TBL] [Abstract][Full Text] [Related]
12. The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT.
Cimenti C; Koestenberger M; Leschnik B; Haidl H; Muntean W
Thromb Res; 2007; 119(3):361-7. PubMed ID: 16712904
[TBL] [Abstract][Full Text] [Related]
13. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
Chan AK; Berry LR; Monagle PT; Andrew M
Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses.
Monreal L; Villatoro AJ; Monreal M; Espada Y; Anglés AM; Ruiz-Gopegui R
Am J Vet Res; 1995 Oct; 56(10):1281-5. PubMed ID: 8928943
[TBL] [Abstract][Full Text] [Related]
15. Kallikrein activates prothrombin.
Stief TW
Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
[TBL] [Abstract][Full Text] [Related]
16. Effect of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers.
Warning A; Nies D; Wolf H; Welzel D
Arzneimittelforschung; 1987 Jul; 37(7):847-9. PubMed ID: 2823841
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
Harenberg J
J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
[TBL] [Abstract][Full Text] [Related]
19. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
Ofosu FA; Smith LM; Anvari N; Blajchman MA
Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracted from Stichopus japonicus Selenka.
Suzuki N; Kitazato K; Takamatsu J; Saito H
Thromb Haemost; 1991 Apr; 65(4):369-73. PubMed ID: 1647552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]